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Summary
Background: In recent years there has been an increase in life-threatening infections caused by
Acinetobacter baumannii with multiple antibiotic resistance, which has lead to the use of
polymyxins, especially colistin, being reconsidered. The aim of this study was to investigate
the colistin sensitivity of A. baumannii isolates with multiple antibiotic resistance via different
methods, and to evaluate the disk diffusion method for colistin against multi-resistant Acine-
tobacter isolates, in comparison to the E-test and Phoenix system.
Methods: The study was carried out on 100 strains of A. baumannii (colonization or infection)
isolated from the microbiological samples of different patients followed in the clinics and
intensive care units of Uludag˘ University Medical School between the years 2004 and 2005.
Strains were identified and characterized for their antibiotic sensitivity by Phoenix system
(Becton Dickinson, Sparks, MD, USA).
Results: In all studied A. baumannii strains, susceptibility to colistin was determined to be 100%
with the disk diffusion, E-test, and broth microdilution methods. Results of the E-test and broth
microdilution method, which are accepted as reference methods, were found to be 100%
consistent with the results of the disk diffusion tests; no very major or major error was identified
upon comparison of the tests. The sensitivity and the positive predictive value of the disk
diffusion method were found to be 100%.
Conclusions: Colistin resistance in A. baumannii was not detected in our region, and disk
diffusion method results are in accordance with those of E-test and broth microdilution methods.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author.
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Colistin, which is synthesized naturally by Bacillus polymyxa,
is a cationic polypeptide antibiotic of the polymyxin family
that is rapidly bactericidal to Gram-negative bacteria. ThePublished by Elsevier Ltd. All rights reserved.
Table 1 Antibiotic susceptibilities of Acinetobacter bau-
mannii strains tested with the Phoenix system
Antibiotic Obtained
MIC value
% resistant
rate (N = 100)
Amikacin >32 100
Aztreonam >16 100
Cefepime >16 100
Ceftazidime >16 100
Ciprofloxacin >2 100
Gentamicin >8 100
Imipenem >8 100
Meropenem >8 100
Piperacillin >64 100
Tobramycin >8 100
Trimethoprim/
sulfamethoxazole
>2/38 100
MIC, minimum inhibitory concentration.
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ing with the structure and function of the outer cytoplasmic
membrane of bacteria, resulting in bacterial death.1,2
Colistin was first introduced in 1952 and was used until the
early 1980s for the treatment of infections caused by Gram-
negative bacilli. Its systemic use was discontinued because of
problems with toxicity, such as nephrotoxicity, neuromuscu-
lar blockade, and neurotoxicity.3,4
Problems in permeability of antibiotics due to the external
membrane structure and the presence of efflux pumps in
Gram-negative bacteria with multiple antibiotic resistance,
the lack of novel antibiotic groups discovered in recent years,
and especially the increase in the rate of life-threatening
infections caused by Acinetobacter spp with multiple anti-
biotic resistance among patients treated in intensive care
units (ICUs), have lead to the use of polymyxins, especially
colistin, being reconsidered, and the performing of antibiotic
sensitivity tests in this group.5
Multidrug-resistant Gram-negative bacilli, mainly Acineto-
bacter baumannii, are encountered in our hospital. The aim of
this study was to investigate the sensitivity to colistin of A.
baumannii isolates with multiple antibiotic resistance; these
isolates were obtained from patients treated in the clinics and
ICUs of our university hospital via different methods.
Methods
This study was carried out on 100 strains of A. baumannii
(colonization or infection) isolated from the microbiological
samples of different patients followed in the clinics and ICUs
of Uludag˘ University Medical School between the years 2004
and 2005. Strains were identified and characterized for their
antibiotic sensitivity by Phoenix system (Becton Dickinson,
Sparks, MD, USA).
Antibiotic sensitivity tests were performed according to
the guidelines of the Clinical and Laboratory Standards Insti-
tute (CLSI, Wayne, PA, USA). BBL-labeled 10-mg disks were
used for the disk diffusion method. For the determination of
minimum inhibitory concentration (MIC) values, the E-test
(AB Biodisk, Solna, Sweden) was performed in addition to the
values obtained in the Phoenix system.
For the E-test method, the bacterial suspension, which
was calibrated to 0.5-McFarland opacity, was cultivated onto
Mueller—Hinton agar in accordance with the manufacturer’s
recommendations, after which the E-test colistin strip (ran-
ging from 0.06 to 1.024 mg/ml) was positioned. MIC values
were determined following 16—20 h of incubation at 35 8C.
Colistin sensitivity in the Phoenix system was evaluated by
the broth microdilution method (ranging from 0.5 to 2 mg/
ml). MIC values that inhibited 50% and 90% of strains were
accepted as MIC50 and MIC90, respectively.
In the disk diffusion method for the evaluation of suscept-
ibility, 11 mm and 8 mm were accepted as sensitive and
resistant, respectively (NCCLS 1981).6 In the E-test and broth
microdilution methods,2 mg/l and4 mg/l were accepted
as sensitive and resistant, respectively (CLSI 2005).7
Errors were ranked as follows: very major error, if the
result of the reference method (E-test and broth microdilu-
tion) was resistant, while that of the disk diffusion test was
sensitive (false-susceptible result) and major error, if the
result of the reference method was sensitive, while that ofthe disk diffusion test was resistant (false-resistant result).
The usefulness of the disk diffusion test method (sensitivity,
specificity, and positive and negative predictive values) for
the detection of colistin resistance in clinical isolates of A.
baumannii was also evaluated. Escherichia coli strain ATCC
25922 was used as the control.
Results
One hundred strains of A. baumannii were studied, of which
17% were isolated from clinics and 83% were isolated from
ICUs (pulmonary diseases, n = 8; hematology, n = 2; infec-
tious diseases, n = 2; general surgery, n = 1; thoracic and
cardiovascular surgery, n = 1; neurosurgery, n = 1; orthope-
dics, n = 1; burn, n = 1; internal medicine ICU, n = 3; general
surgery ICU, n = 13; thoracic and cardiovascular surgery ICU,
n = 3; neurology ICU, n = 7; neurosurgery ICU, n = 9; reani-
mation ICU, n = 44; and trauma ICU, n = 4). Of the isolates,
77% were isolated from deep endotracheal aspiration, 18%
from blood, 3% from catheters, and 2% from wound samples.
The antibiotic susceptibilities of these strains with multiple
antibiotic resistance are shown in Table 1.
In all studied A. baumannii strains, colistin susceptibility
was determined as 100% with the disk diffusion, E-test, and
broth microdilution methods. The disk diffusion and E-test
results are shown in Table 2.
All A. baumannii strains were determined as sensitive to
colistin by Phoenix system (MIC50 and MIC90 values of 0.5 mg/
l); the E-test method revealed colistin MIC50 and MIC90 values
of 0.5 mg/l and 2 mg/l, respectively.
Results of the E-test and broth microdilution method,
which are accepted as reference methods, were found to
be 100% consistent with the results of the disk diffusion tests.
The sensitivity and the positive predictive value of the disk
diffusion method were found to be 100%.
Discussion
A. baumannii is one of the most important agents causing
nosocomial infections, especially in ICUs. Treatment of these
infections is difficult due to the multiple antibiotic resistance
Table 2 Comparison of disk diffusion zone diameters and E-
test MIC values for colistin susceptibility
Disk diffusion
zone diameters
E-test MIC values
0.50 1.00 2.00 Total
11 mm 1 5 13 19
12 mm 6 17 1 24
13 mm 50 3 - 53
14 mm 4 - - 4
Total 61 25 14 100
MIC, minimum inhibitory concentration.
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after the 1980s, due to its nephrotoxic and neurotoxic side
effects. However, more recently it has come back into use as
an effective antibiotic, especially for the treatment of noso-
comial pneumonia and cases of sepsis caused by Gram-nega-
tive bacteria with multiple antibiotic resistance.8,9
We did not detect colistin resistance in our study. We also
found no reports of colistin resistance from other studies in
our country.10—12 However, the use of colistin for serious
infections with multidrug-resistant Acinetobacter spp has
increased and this usage may lead to colistin resistance.13,14
Accurate susceptibility test results are crucial for the
selection of appropriate antibiotic therapy. There is, however,
somecontroversy surrounding susceptibility tests forcolistin in
the microbiology laboratory. Different methods have been
employed for the investigation of colistin sensitivity.
Although the disk diffusion method is one of the most
frequently used techniques in microbiology laboratories, the
poor diffusion of colistin to agar in particular, leads to
problems in the standardization of sensitivity tests per-
formed with this method. Interpretative criteria for disk
susceptibility testing of colistin are not available from the
CLSI, and zone size interpretations are made based on the
product literature. Gales et al. recommended the use of
amended zone diameters for better correlation with refer-
ence methods.5 European guidelines for disk susceptibility
testing have been published by the British Society for Anti-
microbial Chemotherapy (BSAC), The Socie´te´ Franc¸aise de
Microbiologie (SFM), and the German Deutsches Institut fu¨r
Normung (DIN). However, there are differences in these
guidelines with regard to media, colistin quantity, andTable 3 MIC and zone breakpoints for Acinetobacter spp
Guidelines Year MIC
breakpoint
(mg/l)
Interpretation o
S R Disk content (m
BSAC 2006 4 >4 25
SFM 2003 2 >2 50
NCCLS 1981 10
CLSI 2008 2 4
EUCAST 2008 2 >2
MIC, minimum inhibitory concentration; BSAC, British Society for Antim
NCCLS, National Committee on Clinical Laboratory Standards; CLSI, C
Committee on Antimicrobial Susceptibility Testing; S, sensitive; R, resaccepted zone diameters in the disk diffusion method, and
in MIC breakpoints (Table 3). There are no accepted zone
diameters for the disk diffusion method in the guidelines of
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) and the CLSI, however there is similarity
of MIC breakpoints.15
Although agar dilution and brothmicrodilutionmethods are
frequently recommended for the investigation of colistin sus-
ceptibility, there are difficulties in the routine application of
these techniques.Conversely, theE-test is a simplealternative
method for the susceptibility testing of several microorgan-
isms; however, it is expensive for routine use. Nevertheless,
identification and susceptibility tests performed with auto-
mated systems are preferred, particularly in hospitals where
high levels of routine application are required.
In our study 100% consistency was determined between
the three methods upon analyzing the MIC (E-test and Phoe-
nix system) and disk diffusion zone results. It has been
reported that incorrect results may be obtained based on
the interpretation criteria of the disk diffusionmethod, when
different methods are used together in a study for the
investigation of colistin susceptibility. Rodriguez et al. used
two different breakpoints in accordance with the NCCLS 1981
(8 mmand11 mm) and Jones 2001 (11 mmand14 mm)
for the interpretation of disk diffusion test results.When they
compared the agar dilution and disk diffusion methods, they
obtained different results for the disk diffusion method with
the interpretation criteria of NCCLS 1981 (0.5% minor, 2.2%
major, and 4.4% very major error) and Jones 2001 (18.9%
minor, 3.8% major, and 0.5% very major error).16 When we
interpreted our data according to the Jones criteria (11 mm
and 14 mm), the major error rate increased to 19%, and 77
isolates were found to be in the intermediate zone.
Gales et al. compared the broth microdilution test and the
disk diffusion method by using a resistance breakpoint of
4 mg/l and zone diameter of 8 mm. They determined 1%
minor error and 5% very major error.5
Tan and Ng evaluated colistin susceptibility with the agar
dilution method (resistance breakpoint of 4 mg/l) and the
disk diffusion method (resistance zone diameter of 8 mm,
susceptible zone diameter of 11 mm); they showed 100%
correlation of results of the agar dilution and disk diffusion
methods for colistin susceptibility in 61 Acinetobacter spp
isolates. They determined that all isolates were susceptible,
as we found in our study.17f zone diameters (mm)
g) Medium S I R
Isosensitest agar 15 — 14
Mueller—Hinton agar 15 — <15
Mueller—Hinton agar 11 — 8
icrobial Chemotherapy; SFM, Socie´te´ Franc¸aise de Microbiologie;
linical and Laboratory Standards Institute; EUCAST, the European
istant; I, intermediate.
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test and broth microdilution (used as the reference method)
in 115 clinical isolates of A. baumannii. Colistin susceptibility
was determined as 80.8% in their study, and they obtained
98.2% correlation between the E-test and brothmicrodilution
methods. In this study, where the colistin susceptibility was
determined as 80.8%, no major error was identified during
comparison of the tests. A very major error was identified in
two isolates, and sensitivity, specificity, and positive and
negative predictive values of the E-test were reported as
90.9%, 100%, 100%, and 97.8%, respectively.14
We found a 100% categorical agreement between the E-
test and disk diffusion test. We detected that no isolates
were resistant to colistin in our study. Galani et al. performed
antimicrobial susceptibility tests for colistin by using the E-
test and disk diffusion method. They used resistance break-
points of 4 mg/l according to the CLSI 2007 criteria and
zone diameters of 12 mm for resistance, 14 mm for sus-
ceptibility, and 13 mm for the intermediate category. Among
the 226 Acinetobacter isolates, they found nine resistant by
E-test. Eight resistant isolates exhibited zone diameters of
12 mm and only one isolate exhibited a zone diameter of
13 mm in this study. Among the nine isolates displaying a zone
diameter of 13 mm, only one isolate was found to be resistant
with a MIC of 8 mg/l.18
Based on our findings, we are unable to propose that the
disk diffusion technique is reliable for colistin susceptibility
testing, although different criteria were used.
The reliability of automated susceptibility testing systems
like VITEK 2 for the evaluation of colistin susceptibility in
Acinetobacter spp remains controversial. Lo-Ten-Foe et al.
compared the VITEK 2 and broth microdilution methods for
colistin susceptibility and found a high level of agreement.
They also reported a high level of agreement between the E-
test and broth microdilution method. They showed the disk
diffusion method to be unreliable in their study.19
Tan and Ng compared the E-test and VITEK 2 with agar
dilution for colistin susceptibility in 58 Acinetobacter spp.
They reported one major error for the E-test and no major
error for VITEK 2. They showed 100% categorical agreement
between the VITEK 2 and agar dilution. All Acinetobacter
isolates also were susceptible in their study.20
In our study, we found 100% categorical agreement
between the Phoenix system and the E-test. This is the first
study to compare the Phoenix system and the E-test.
In conclusion, the broth microdilution method and agar
dilution are accepted as reference methods for colistin
susceptibility testing. However, differences have been
reported between the two tests.5 Based on the studies
reported, it would appear that the E-test is a reliable method
for colistin susceptibility testing.14,18—20 However, further
studies on automated systems and disk diffusion methods
are required. In addition, the standardization of susceptibil-
ity tests for colistin is needed.
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